At the forefront of the fight
against bacterial infections
Welcome
Welcome to the Pherecydes Pharma investor website,
Here you will find all the financial information dedicated to shareholders and investors.
Press release
05/23/2023 - 22:53
Availability of the Exemption document
04/17/2023 - 07:00
Pherecydes Pharma presented its Phagogram 1.5 at the ECCMID Congress
Subscribe to email alert
Ask us your questions
Contacts
Pherecydes Pharma
Thibaut du Fayet
CEO
Email : This email address is being protected from spambots. You need JavaScript enabled to view it.
NewCap
Investor Relations & Strategic Communication
Dusan Oresansky
+33 (0)1 44 71 94 92
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Medias Relations
Nicolas Merigeau
+33 (0)1 44 71 94 98
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.